68
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

The place of pemetrexed in the management of non-small-cell lung cancer patients

, , &
Pages 257-266 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Huai-Qing Xiao, Rong-Hua Tian, Zhi-Hao Zhang, Kai-Qi Du & Yi-Ming Ni. (2016) Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis. OncoTargets and Therapy 9, pages 1471-1476.
Read now
Xin Li, Sen Wei & Jun Chen. (2014) Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules. OncoTargets and Therapy 7, pages 937-945.
Read now

Articles from other publishers (5)

J.H. Kim, S.H. Kim, M.K. Jeon, J.E. Kim, K.H. Kim, K.-H. Yun, H.-C. Jeung, S.Y. Rha, J.-H. Ahn & H.S. Kim. (2021) Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial. ESMO Open 6:5, pages 100249.
Crossref
Jungang Chen, Haiwei Zhang & Xulin Chen. (2020) Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis. Antiviral Research 180, pages 104825.
Crossref
Mike R. Wilson, Zhanjun Hou, Si Yang, Lisa Polin, Juiwanna Kushner, Kathryn White, Jenny Huang, Manohar Ratnam, Aleem Gangjee & Larry H. Matherly. (2016) Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3- d ]Pyrimidine Thienoyl Antifolates . Molecular Pharmacology 89:4, pages 425-434.
Crossref
Li‐Yan Zhou, Ye‐Hui Shi, Yong‐Sheng Jia & Zhong‐Sheng Tong. (2015) Potential role of pemetrexed in metastatic breast cancer patients pre‐treated with anthracycline or taxane. Chronic Diseases and Translational Medicine 1:1, pages 27-35.
Crossref
WEN-XI YU, LI-NA TANG, FENG LIN, YANG YAO & ZAN SHEN. (2014) Comparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single institute. Oncology Letters 8:5, pages 2243-2248.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.